Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.61
Delayed Data
As of Dec 07
 0.00 / 0.00%
Today’s Change
5.21
Today|||52-Week Range
16.30
-14.41%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.61
Today’s openn.a.
Day’s range-- - --
Volume1,619
Average volume (3 months)1,056,488
Market cap$355.0M
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-8.04%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.59

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.08-5.41%
CRBPCorbus Pharmaceutica...0.000.00%
FOMXFoamix Pharmaceutica...-0.20-2.02%
SVASinovac Biotech Ltd+0.05+0.82%
Data as of 12/07/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs